Volume 21, Number 7—July 2015
Research
Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia
Table 2
Next-generation sequencing of 25 Ebola virus isolates derived from selected patients sampled, Liberia, September 2014–February 2015
Sample ID | Coverage, %* | No. reads | Finishing category† | GenBank accession no. |
---|---|---|---|---|
LIBR0093 | 99.4 | 169,000 | Coding complete | KR006947 |
LIBR0116 | 97.9 | 710,168 | Coding complete | KR006948 |
LIBR10054 | 98 | 2,150,725 | Coding complete | KR006964 |
LIBR0073 | 98.5 | 3,351,831 | Coding complete | KR006944 |
LIBR0503 | 98.9 | 3,193,168 | Coding complete | KR006956 |
LIBR0286 | 98.3 | 1,731,953 | Coding complete | KR006952 |
LIBR0993 | 96.5 | 750,000 | Standard draft | KR006960 |
LIBR0423 | 97.1 | 2,676,454 | Standard draft | KR006954 |
LIBR0333 | 97.1 | 1,775,653 | Standard draft | KR006953 |
LIBR10053 | 98 | 1,691,652 | Standard draft | KR006963 |
LIBR0067 | 97 | 2,403,590 | Standard draft | KR006943 |
LIBR0092 | 93.9 | 2,758,142 | Standard draft | KR006946 |
LIBR0090 | 93.1 | 1,422,271 | Standard draft | KR006945 |
LIBR1413 | 88.2 | 2,500,000 | Standard draft | KR006962 |
LIBR0058 | 91.4 | 1,632,978 | Standard draft | KR006940 |
LIBR0176 | 89.4 | 1,907,863 | Standard draft | KR006951 |
LIBR0168 | 89.2 | 1,221,075 | Standard draft | KR006949 |
LIBR0505 | 83.8 | 741,165 | Standard draft | KR006957 |
LIBR1195 | 73.1 | 2,200,773 | Standard draft | KR006961 |
LIBR0624 | 68 | 1,550,511 | Standard draft | KR006959 |
LIBR0063 | 69 | 2,883,384 | Standard draft | KR006942 |
LIBR0173 | 72.3 | 1,456,490 | Standard draft | KR006950 |
LIBR0059 | 59.1 | 851,606 | Standard draft | KR006941 |
LIBR0605 | 64.7 | 1,587,732 | Standard draft | KR006958 |
LIBR0430 | 56.2 | 3,139,009 | Standard draft | KR006955 |
*Percentage of genome bases (of 18,959 total bases) called in the consensus sequences (requires >3× coverage with base quality >20).
†Categories are defined in (19).
References
- Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Emergence of Zaire Ebola virus disease in Guinea—preliminary report. N Engl J Med. 2014;371:1418–25 . DOIPubMedGoogle Scholar
- Hawkes N. Ebola outbreak is a public health emergency of international concern, WHO warns. BMJ. 2014;349:g5089. DOIPubMedGoogle Scholar
- Yozwiak NL, Schaffner SF, Sabeti PC. Data sharing: make outbreak research open access. Nature. 2015;518:477–9. DOIPubMedGoogle Scholar
- World Health Organization. Ebola situation report—11 March 2015 [cited 2015 Mar 30]. http://apps.who.int/ebola/current-situation/ebola-situation-report-11-march-2015
- Chan M. WHO report by the Director-General to the special session of the Executive Board on Ebola [cited 2015 Mar 30]. http://www.who.int/dg/speeches/2015/executive-board-ebola/en/
- Kugelman JR, Sanchez-Lockhart M, Andersen KG, Gire S, Park DJ, Sealfon R, Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics. MBio. 2015;6:e02227–14. DOIPubMedGoogle Scholar
- Shuchman M. WHO enters new terrain in Ebola research. CMAJ. 2014;186:E527–8. DOIPubMedGoogle Scholar
- Sayburn A. WHO gives go ahead for experimental treatments to be used in Ebola outbreak. BMJ. 2014;349:g5161. DOIPubMedGoogle Scholar
- Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010;82:954–60. DOIPubMedGoogle Scholar
- Kuhn JH, Andersen KG, Baize S, Bao Y, Bavari S, Berthet N, Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 2014;6:4760–99. DOIPubMedGoogle Scholar
- Djikeng A, Halpin R, Kuzmickas R, Depasse J, Feldblyum J, Sengamalay N, Viral genome sequencing by random priming methods. BMC Genomics. 2008;9:5. DOIPubMedGoogle Scholar
- Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345:1369–72. DOIPubMedGoogle Scholar
- Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17:10–2.
- Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011;27:863–4. DOIPubMedGoogle Scholar
- Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–9. DOIPubMedGoogle Scholar
- Cingolani P, Platts A. Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6:80–92.
- Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29:1969–73. DOIPubMedGoogle Scholar
- Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–21. DOIPubMedGoogle Scholar
- Ladner JT, Beitzel B, Chain PS, Davenport MG, Donaldson EF, Frieman M, Standards for sequencing viral genomes in the era of high-throughput sequencing. MBio. 2014;5:e01360–14. DOIPubMedGoogle Scholar
- Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 2010;375:1896–905. DOIPubMedGoogle Scholar
- Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med. 2010;16:991–4. DOIPubMedGoogle Scholar
- Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep. 2013;3:3365.
- Pettitt J, Zeitlin L, Kim DH, Working C, Johnson JC, Bohorov O, Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med. 2013;5:199ra113. PMID: 23966302
- Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014;514:47–53 .PubMedGoogle Scholar
- Olinger GG Jr, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A. 2012;109:18030–5. DOIPubMedGoogle Scholar
- Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci U S A. 2012;109:5034–9. DOIPubMedGoogle Scholar
- Heald AE, Iversen PL, Saoud JB, Sazani P, Charleston JS, Axtelle T, Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against Ebola virus and Marburg virus: results of two single-ascending-dose studies. Antimicrob Agents Chemother. 2014;58:6639–47. DOIPubMedGoogle Scholar
- Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol. 2013;158:301–11. DOIPubMedGoogle Scholar
- Rezler JP. Tekmira provides periodic update on TKM-Ebola program [cited 2015 Mar 30]. http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=877397
- Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Epitopes involved in antibody-mediated protection from Ebola virus. Science. 2000;287:1664–6. DOIPubMedGoogle Scholar
- Qiu X, Alimonti JB, Melito PL, Fernando L, Stroher U, Jones SM. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol. 2011;141:218–27 . DOIPubMedGoogle Scholar
- Towner JS, Paragas J, Dover JE, Gupta M, Goldsmith CS, Huggins JW, Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology. 2005;332:20–7. DOIPubMedGoogle Scholar
- Swenson DL, Warfield KL, Warren TK, Lovejoy C, Hassinger JN, Ruthel G, Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrob Agents Chemother. 2009;53:2089–99. DOIPubMedGoogle Scholar
- Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K, Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J Infect Dis. 2006;193:1650–7. DOIPubMedGoogle Scholar
- Theriault S, Groseth A, Neumann G, Kawaoka Y, Feldmann H. Rescue of Ebola virus from cDNA using heterologous support proteins. Virus Res. 2004;106:43–50. DOIPubMedGoogle Scholar
- Martínez MJ, Biedenkopf N, Volchkova V, Hartlieb B, Alazard-Dany N, Reynard O, Role of Ebola virus VP30 in transcription reinitiation. J Virol. 2008;82:12569–73. DOIPubMedGoogle Scholar
- Biedenkopf N, Hartlieb B, Hoenen T, Becker S. Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication. J Biol Chem. 2013;288:11165–74. DOIPubMedGoogle Scholar
- Carroll SA, Towner JS, Sealy TK, McMullan LK, Khristova ML, Burt FJ, Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol. 2013;87:2608–16. DOIPubMedGoogle Scholar
- World Health Organization. Mali: details of the additional cases of Ebola virus disease [cited 2015 Mar 30]. http://www.who.int/mediacentre/news/ebola/20-november-2014-mali/en/
1These authors contributed equally to this article.